|
JP2007297339A
|
|
Medicine for treating or examining cancer
|
|
JP2006169156A
|
|
Nafamostat mesilate as immunoregulator
|
|
JP2005192888A
|
|
Medicament container
|
|
JP2003246730A
|
|
Tryptase inhibitor
|
|
JP2003108002A
|
|
Multilayered label for medicine management
|
|
JP2002372539A
|
|
Detection method and device of antibody against nonprotein substance
|
|
JP2001097948A
|
|
Compound having affinity for thrombopoietin receptor
|
|
JP2000237312A
|
|
Drug housing kit
|
|
JP2000247902A
|
|
Medicine in vivo histological distribution promoter
|
|
JP2000189494A
|
|
Medicine-solution integral kit
|
|
JP2000159751A
|
|
Benzene derivative
|
|
JP2002275157A
|
|
New naphthalene derivative
|
|
JP2000119177A
|
|
Analgesic
|
|
JPH10158225A
|
|
Inhibitor for producing virus
|
|
JPH09157160A
|
|
Inactivation inhibitor of virus vector
|
|
JPH08198826A
|
|
Compound having antiviral activity
|
|
JPH08119952A
|
|
Isatoic acid anhydride derivative
|
|
JPH08119919A
|
|
Benzoic acid orth-substituted phenyl ester derivative
|
|
JPH08119922A
|
|
Orth-pivaloyl-thyrosine derivative
|
|
JPH08109176A
|
|
Isorhodanine n acetic acid derivative
|
